Skip Navigation



JAC Advance Access published online on June 15, 2005
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dki199
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
56/2/282    most recent
dki199v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lawson, A. J.
Right arrow Articles by Owen, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lawson, A. J.
Right arrow Articles by Owen, R. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oupjournals.org
Received May 4, 2005
Accepted May 20, 2005

Original article

Real-time PCR detection and frequency of 16S rDNA mutations associated with resistance and reduced susceptibility to tetracycline in Helicobacter pylori from England and Wales

Andrew J. Lawson 1*, Nicola C. Elviss 1, and Robert J. Owen 1

1 Campylobacter and Helicobacter Reference Unit, Laboratory of Enteric Pathogens, Health Protection Agency Centre for Infections, 61 Colindale Avenue, London NW9 5HT, UK

* To whom correspondence should be addressed.
Andrew J. Lawson, E-mail: andy.lawson{at}hpa.org.uk


  Abstract

Objectives: To investigate the occurrence of 16S rDNA mutations associated with resistance or reduced susceptibility to tetracycline in Helicobacter pylori isolated in England and Wales, and to develop a real-time PCR assay to detect these DNA polymorphisms from culture and gastric biopsies.

Methods: Tetracycline susceptibility was determined by disc diffusion. The MIC of isolates with reduced susceptibility was determined by Etest and agar dilution methods. The 16S rDNA of these isolates was sequenced and resistance-associated mutations identified. A LightCycler assay developed to detect these mutations was applied to DNA extracted from culture and gastric biopsies.

Results: From 1006 isolates of H. pylori examined, 18 showed reduced susceptibility to tetracycline. Of these, three were resistant (≥4 mg/L). Mutations in 16S rDNA were detected in 10 of the reduced susceptibility isolates: one double base mutation of A926T/A928C, one A926C, one A928C; and seven A926G. The first two polymorphisms were novel and had not been reported from clinical isolates previously. The LightCycler assay identified each of the 10 isolates with 16S rDNA mutations, but did not detect polymorphisms in 100 tetracycline-susceptible H. pylori isolates. The assay correctly determined the tetracycline susceptibility of H. pylori in 20 gastric biopsy samples.

Conclusions: Mutations in 16S rDNA were detected in H. pylori isolated in England and Wales with reduced susceptibility to tetracycline, but resistance to this antibiotic was uncommon. We show molecular-based susceptibility testing for tetracycline is possible direct from biopsy material.

Keywords: antimicrobial resistance mechanisms; LightCycler; DNA polymorphisms.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Med MicrobiolHome page
M. Anoushiravani, T. Falsafi, and V. Niknam
Proton motive force-dependent efflux of tetracycline in clinical isolates of Helicobacter pylori
J. Med. Microbiol., October 1, 2009; 58(10): 1309 - 1313.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
E. Glocker and M. Kist
Emergence of a Helicobacter pylori isolate with reduced susceptibility to tetracycline in Germany
J. Antimicrob. Chemother., November 1, 2006; 58(5): 1103 - 1104.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.